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Abstract Congenital diaphragmatic hernia (CDH) is a
life-threatening anomaly with a mortality rate of approxi-
mately 40–50%, depending on case selection. It has
been suggested that new therapeutic modalities such as
nitric oxide (NO), high frequency oxygenation (HFO)
and extracorporal membrane oxygenation (ECMO) might
decrease mortality associated with pulmonary hypertension
and the sequelae of artificial ventilation. When these new
therapies indeed prove to be beneficial, a larger number of
children with severe forms of CDH might survive, resulting
in an increase of CDH-associated complications and/or
consequences. In follow-up studies of infants born with
CDH, many complications including pulmonary damage,
cardiovascular disease, gastro-intestinal disease, failure to
thrive, neurocognitive defects and musculoskeletal abnor-
malities have been described. Long-term pulmonary
morbidity in CDH consists of obstructive and restrictive
lung function impairments due to altered lung structure and
prolonged ventilatory support. CDH has also been associ-
ated with persistent pulmonary vascular abnormalities,
resulting in pulmonary hypertension in the neonatal period.
Long-term consequences of pulmonary hypertension are
unknown. Gastro-esophageal reflux disease (GERD) is also
an important contributor to overall morbidity, although the
underlying mechanism has not been fully understood yet. In
adult CDH survivors incidence of esophagitis is high and
even Barrett’s esophagus may ensue. Yet, in many CDH
patients a clinical history compatible with GERD seems to
be lacking, which may result in missing patients with
pathologic reflux disease. Prolonged unrecognized GERD
may eventually result in failure to thrive. This has been
found in many young CDH patients, which may also be
caused by insufficient intake due to oral aversion and
increased caloric requirements due to pulmonary morbidity.
Neurological outcome is determined by an increased risk of
perinatal and neonatal hypoxemia in the first days of life of
CDH patients. In patients treated with ECMO, the incidence
of neurological deficits is even higher, probably reflecting
more severe hypoxemia and the risk of ECMO associated
complications. Many studies have addressed the substantial
impact of the health problems described above, on the
overall well-being of CDH patients, but most of them
concentrate on the first years after repair and only a few
studies focus on the health-related quality of life in CDH
patients. Considering the scattered data indicating sub-
stantial morbidity in long-term survivors of CDH, follow-
up studies that systematically assess long-term sequelae are
mandatory. Based on such studies a more focused approach
for routine follow-up programs may be established.
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Introduction
Congenital diaphragmatic hernia (CDH) is a life-threatening
congenital anomaly, with an incidence of approximately
1:2,500 live births [1, 2]. Despite advances in antenatal
diagnosis and postnatal management, mortality rate remains
stable around 40–50% [1–4]. It has been shown that overall
survival rate is mainly determined by the rate of antenatal
termination, the incidence of CDH associated anomalies,
degree of pulmonary hypoplasia and pulmonary hyperten-
sion in the neonatal period [1, 2, 5–7]. Reports of improved
survival of CDH should be interpreted with caution, as
variations in outcomes are more likely to be explained by
case selection bias [2].
The incidence of malformations associated with CDH
is 33–50% [1, 3, 8, 9]. Major anomalies, like cardiovas-
cular defects, intestinal atresias and chromosomal
anomalies [1, 3, 10] may all contribute to a fatal outcome
[1–3, 8, 11–13]. Several non-life threatening anomalies
such as atrial or ventricular septal defect, Meckel’s
diverticulum, neurological abnormalities and genito-uri-
nary abnormalities are also more frequently observed in
CDH patients [3, 8].
In the past decades, new pathophysiologic concepts have
been developed, leading to a change in therapeutic
approach. Before 1985, surgical repair was performed on
an emergency basis, because it was believed that removing
the abdominal viscera from the chest allowed expansion of
the lung on the involved side [14]. It was observed, how-
ever, that the clinical condition of children with CDH
rarely, if ever, improved after emergency surgery; in fact,
many children were significantly worse postoperatively
[15]. This could be explained by the fact that pulmonary
vascular resistance rapidly increases due to a variety of
stimuli including endotracheal tube suctioning, loud
ambient noise, pain, hypothermia and atelectasis. All of
these stimuli are enhanced during repair of the diaphragm.
Furthermore it was demonstrated that surgical reduction of
the hernia does not improve lung mechanics and may even
temporarily decrease the compliance of the chest wall [16,
17]. This can be explained by increased abdominal pressure
associated with reduction of the viscera into the small
abdominal cavity [16, 17].
When it was realized that surgical repair could further
decrease lung compliance, which could be fatal in a patient
already compromised by pulmonary hypoplasia and per-
sistent pulmonary hypertension, repair was delayed and
performed after patients were stabilized and adequately
oxygenated with minimal ductal shunting on conventional
ventilation [4, 18]. Delayed surgery is theorized to provide
additional time for remodeling of the pulmonary vascula-
ture, leading to a more stable infant, who is better able to
tolerate a postoperative decrease in compliance [16, 19].
Although a significant change in survival after the intro-
duction of delayed surgery was not observed [4, 20–22], a
strategy of delaying correction of the defect for some
period of time have been adopted by centers, with the
majority of patients undergoing operation beyond 24 h of
age [23, 24].
The introduction of ECMO in the early 1980s was
expected to improve the outcome for infants with pul-
monary hypertension refractory to maximal conventional
medical management. Roughly 50% of infants with high-
risk CDH are treated with ECMO [25, 26], the results,
however, remain disappointing [2, 21, 27]. Some authors
reported an improved survival rate when incorporating
ECMO as a preoperative stabilization or postoperative
rescue therapy [26, 28, 29], while others found a relatively
unchanged mortality rate [2, 21, 22, 27, 30]. It is difficult to
accurately compare results of those studies because each
center varies in degree of illness, ventilatory management,
timing of surgery, ECMO and selection criteria for ECMO.
Another confounding feature of reports of survival in CDH
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patients treated with ECMO is the unreliability of historic
controls [2, 26, 27]. Furthermore, most studies have a
relatively short follow-up period, while significant late
mortality has been found in CDH patients treated with
ECMO [31]. If the use of ECMO has indeed a beneficial
effect on survival, than it might be possible that a larger
number of severely affected infants would nowadays sur-
vive [32]. It is likely that these infants will have more
severe pulmonary hypoplasia and pulmonary hypertension
[26, 31, 33] implying more serious long-term morbidity
[31].
The last decade fetal endoscopic tracheal occlusion (TO)
has been developed as an alternative strategy to promote
fetal lung growth by preventing normal outflow of lung
fluid. Occlusion of the fetal trachea was shown to stimulate
fetal growth in a variety of animal models [34–40]. On the
other hand, prematurity caused by the intervention itself
can be detrimental. Results of studies regarding survival
rate and TO are ambiguous and it is not yet clear whether
survival rates will improve with this new technique [41].
Harrison et al. [42] showed in a (small) randomized con-
trolled trial comparing fetal endoscopic TO to standard
care that mortality is equal. Data concerning long-term
outcomes of fetal endoscopic TO are very scarce [43, 44].
Traditionally most attention has been focused on ther-
apies that reduce perinatal and neonatal mortality, while
relatively few studies have addressed the chronic morbidity
and long-term outcome. In follow-up of infants born with
CDH, many complications have been described. In the
following sections, we will describe the pulmonary, car-
diovascular and gastro-intestinal morbidity secondary to
CDH. We will also discuss failure to thrive, neurodevel-
opmental outcomes, musculoskeletal abnormalities and
health-related quality of life in CDH patients.
Pulmonary morbidity
Structural lung abnormalities and the influence
of treatment
One of the major characteristics of CDH is pulmonary
hypoplasia and an altered lung structure, consisting of a
reduced number of bronchi, a reduced number of alveoli
and structural abnormalities of the pulmonary vascular bed.
The latter will be discussed in the next section. The number
of normal bronchi is reduced in the ipsilateral lung and to a
lesser degree in the contralateral lung [45, 46]. Beals et al.
[45] showed that the number of bronchi did not increase in
time, which is compatible with Reid’s statement [47] that
‘‘bronchial development is complete by 16 weeks of life’’.
The alveolar number on the other hand, can increase over
time. A significant increase in alveolar number in the
contralateral lung, in contrast to the ipsilateral lung, was
found in patients with CDH who deceased before they were
8 days old, between 8 and 21 days old and after they were
21 days old. [45]. Compared to normal lung tissue, there
was still a reduction of the number of alveoli [6, 45] in the
ipsilateral lung and to a lesser degree in the contralateral
lung. In addition to the increase in alveolar number, it has
been shown that size of alveoli may increase [46], resulting
in overdistension of the alveoli to fill the hemithorax after
repair [48]. In addition to structural lung abnormalities,
treatment may also contribute to pulmonary morbidity. In
the past, one of the treatment strategies has been the use of
hyperventilation to achieve alkalosis. The principle of this
hyperventilatory-induced alkalosis was used to reduce
pulmonary vascular resistance and to reverse ductal
shunting. This approach frequently requires high peak
airway pressures and these may cause lung injury [4, 49].
Lung injury, secondary to mechanical ventilation can result
in pulmonary edema and protein leak, also known as
ventilator-induced lung injury [50], resulting in denatur-
ation of surfactant and consequently lung damage [51].
This ventilator-induced lung injury due to high pressure
ventilation appears to be one of the major contributors to
mortality in CDH patients [4, 49, 52, 53] and therefore the
strategy of high pressure ventilation has been abandoned.
Since the introduction of ‘‘permissive hypercapnia’’ (i.e,
allowing higher concentrations of carbon dioxide in the
blood to prevent barotrauma), an improved survival rate
has been documented [4, 19, 49, 52]. Nevertheless, baro-
trauma is still an important contributing factor to lung
injury, which could possibly be further reduced by the use
of ECMO [28]. But as stated before, the benefits of ECMO
in CDH and the effect of ECMO in the long term are
controversial. It has been demonstrated that neonatal
ECMO survivors treated for meconium aspiration syn-
drome experience lung injury, such as hyperinflation,
airway obstruction and lower-oxygen saturation with
exercise, in later childhood [54]. This finding persisted
when they were compared to non-ECMO treated survivors
[55]. Others found that the pulmonary function of ECMO
treated infants (non-CDH) appeared to be slightly better
than that of infants treated conventionally [56].
Fetal tracheal occlusion
In animal experiments, fetal TO has been shown to
accelerate lung growth [57], on the other hand, surfactant
deficiency associated with TO could lead to deterioration in
lung function with longer periods of ventilation [58].
Effects on pulmonary function of CDH patients treated
with fetal TO are preliminary. Keller et al. [43] measured
respiratory mechanics in the first 24 h after birth, before
CDH repair, immediately after repair and before elective
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extubation. They found that fetal TO for severe CDH
results only in modest improvements in neonatal pulmon-
ary function. Cortes et al. [44] performed a follow-up study
of 16 CDH survivors, 7 of them were treated with fetal TO.
Percentages of patients needing oxygen supplementation
after discharge and use of pulmonary medications were
similar in both groups. Pulmonary function (n = 13) did
not differ between the groups.
Respiratory symptoms
Several follow-up studies exploring respiratory symptoms
in CDH survivors yield contradictory results. Symptoms
like coughing or recurrent respiratory infections have been
reported by 25–50% of affected children, especially in the
first year of life [48, 59–61]. Bronchodilators and inhaled
steroids were, at least transiently, used by the majority of
CDH patients, during the first year of life and thereafter [61,
62]. In other studies, however, none of the participating
children had significant respiratory symptoms [63, 64],
suggesting that CDH patients were doing well, regarding
long-term pulmonary outcome. Despite the subjective
impression that CDH survivors older than 2 years generally
were doing well, objective data are scarce, due to a limited
number of included patients [62, 65].
Pulmonary function
Spirometric testing of CHD patients revealed evidence of
obstructive airway disease [64] when compared with
healthy controls [48, 62, 64, 66–69]. Some authors describe
that one-third of the CDH patients have reduced forced
expiratory volume in 1 s (FEV1) and forced vital capacity
(FVC) [62, 69]. FEV1 is an index for assessing airway
obstruction and is often performed in conjunction with
FVC, i.e. the volume of air that can be forcibly and max-
imally exhaled out of the lungs. FEV1 and/or FEV1/FVC
are decreased in patients with airway obstruction. Wis-
cherman et al. [59] reported normal FEV1 in CDH patients,
but found a tendency to obstruction of the smaller airways
illustrated by reduction in the mid-expiratory flow rate and
raised specific airway resistance. There was no correlation
between the extent of pulmonary hypoplasia, assessed
during the operation and by pre-and postoperative chest X-
rays, and reduction of airflow rate [59]. Although FEV1
improves in approximately half of the patients after bron-
chodilator therapy [68, 69], it remains significantly lower
when compared to healthy subjects [69]. Furthermore,
there is evidence for more peripheral airway obstruction in
CDH patients [69] possibly due to structural abnormalities
in distal airways [69]. It has been speculated that there
must be some degree of emphysema because of the finding
of a high residual volume total lung capacity (RV/TLC)
ratio, despite the lack of airway dysfunction [66]. Others
suggest that the high RV/TLC ratio (index for the amount
of trapped air after full exhalation) is associated with chest
wall deformity [68]. Trachsel et al. demonstrated that CDH
patients with a chest wall deformity (moderate to severe
pectus excavatum) had a significantly higher RV/TLC ratio
(40.4 vs. 27.9%). It has been known that pectus excavatum
patients have slightly impaired pulmonary function, which
may be due to decreased compliance of the chest wall [70].
It is hypothesized that reduced-lung tissue and conse-
quent alveolar distension may result in early airway closure
as found in the aging emphysematous lung, which could be
an additional risk factor in the development of chronic
obstructive disease on the longer term [48, 71]. Some long-
term follow-up studies indicate a higher incidence of
restrictive lung function impairment among CDH patients
compared to the healthy population [63, 65] especially
when there was a large diaphragmatic defect [65], while
others cannot confirm this finding [59, 66]. Overall CDH
patients appear not to have an important reduction of total
lung capacity in their school-and adolescence years [66, 68,
69].
A negative correlation has been demonstrated between
the duration of ventilation and pulmonary function at fol-
low-up [63, 69], illustrated by the fact that CDH patients
who had been ventilated for more than 7 days had signif-
icantly lower FEV1 and vital capacity (VC) than CDH
patients who had been ventilated for less than 7 days [69].
This could reflect the severity of the pulmonary disease
[63], but can also be the consequence of ventilator induced
barotrauma. Sakurai et al. [49] found microscopic evidence
of significant pulmonary injury related to the pressure
effects of mechanical ventilation in deceased infants with
CDH, implying destruction of the alveolar-capillary
membrane. The diffusion capacity (i.e. rate at which a gas
diffuses through the alveolar-capillary membrane) cor-
rected for alveolar volume (DLCO/V0A) however, appears
to be normal in CDH patients compared to healthy subjects
[68, 69] suggesting that the alveolar membrane is not
damaged [69].
Sport practice and cardiopulmonary exercise testing
CDH patients achieve normal aerobic capacity (V0O2max)
(an index for maximal oxygen uptake during maximal
exercise; it can determine an athlete’s capacity and is
linked to aerobic endurance) when performing a maximal
exercise test [66], which is compatible with the normal
diffusion capacity that has been described [69, 72].
Nonetheless, Italian investigators report significantly lower
V0O2max for CDH patients representing a decreased degree
of physical fitness [67]. This could (partially) be explained
by the fact that Italian law strictly regulates access to sports
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by requiring a thorough medical examination before the
start of sports activity and that CDH patients may therefore
not practice sport regularly. When comparing CDH
patients active in sports and controls active in sports, the
difference in V0O2max still remained [67]. All participating
patients considered themselves healthy and they did not
have any particular symptom. In the study from Marven
et al. [66], CDH patients perceived their own fitness to be
worse than the healthy control group. Other studies dem-
onstrate that around 20% of interviewed CDH patients
consider themselves less fit than their healthy peers [59, 65,
73]. It seems most likely that the decreased V0O2max found
by Zaccara et al. is due to a lower degree of physical
fitness. Fitness can be increased by regular motor activity
and therefore they recommend active sports participation
for CDH children.
It can be concluded that, although patients surviving
CDH do not have many respiratory symptoms in their (pre-
)school years, the majority of CDH survivors have some
degree of obstructive and/or restrictive airway disease when
carefully examined. The diffusion capacity appears to be
normal but a significantly lower V0O2max has been dem-
onstrated in CDH survivors possibly representing a lower
degree of physical fitness, though the number of patients
who were investigated in this study was rather small.
CDH survivors might be at risk for developing pul-
monary emphysema due to consequent alveolar distension,
but it remains unclear whether the alveolar membrane has
been damaged. Also the introduction of more advanced
interventions, such as fetal TO requires more research on
long-term pulmonary function has to be done to further
clarify CDH associated pulmonary sequelae.
Cardiovascular morbidity
Pulmonary vasculature
In addition to structural abnormalities of alveoli and air-
ways in infants born with CDH, the pulmonary vascular
bed also appears to be abnormal. Several studies have
shown that under normal conditions, when approaching full
term, pulmonary arteries show reduction in medial thick-
ness [74–76]. Molecular basis underlying these changes in
pulmonary vasculature during gestation are not known yet.
The role of vascular smooth muscle cells appears to be
crucial [77]. The physiologic reduction in medial thickness
when approaching full term was not observed in CDH
lungs [76–78]. Pulmonary vascular abnormalities in CDH
consist of decreased number of pulmonary arteries per unit
lung volume and an increase in the medial, adventitial and
consequently total wall thickness of all arteries [4, 45,
76–81]. Due to failure of vascular remodeling, peripheral
muscularization of pulmonary arterioles resulted in par-
ticularly medial and adventitial thickening [15, 78, 79, 81].
The arterioles are predominantly responsible for pulmon-
ary vascular resistance [15, 79].
ECMO and pulmonary vasculature
There are differences observed between lungs of ECMO
treated CDH patients and lungs of non-ECMO treated CDH
patients. Whereas adventitial thickness and total-wall
thickness appeared to be reduced in ECMO-treated CDH
patients when compared to non-ECMO CDH patients,
medial thickness remained increased [77, 82]. Although
pulmonary arterial pressure decreases during 2 weeks of
ECMO, the small acinar arteries remain thick-walled.
Therefore ECMO may result in remodeling or muscle
relaxation [82], ameliorating pulmonary hypertension.
Beals et al. [45] found fewer numbers of arteries with
increased muscular wall thickness and a lower percentage
of muscularization of arteries in deceased infants with
CDH with increasing age suggesting that natural history
may also play a role. A number of these infants had been
treated with ECMO. These results are consistent with the
experience that the tendency to pulmonary hypertension
decreases over time [45]. Unfortunately, the time period
over which these changes occur exceeds the current limi-
tations of invasive support measures such as ECMO [45].
TO might be a promising alternative, since it has been
shown that this intervention can reverse the pulmonary
arterial structural changes that are seen in the nitrofen-
induced fetal rat model of CDH, suggesting that TO might
reduce pulmonary vascular reactivity [83]. More research
in this area is mandatory.
Apart from the pulmonary vascular abnormalities
observed in CDH patients, an altered expression of several
factors may be involved in regulation of the vascular tone
[84, 85]. All these factors together may predispose infants
born with CDH for pulmonary hypertension [45, 76, 77].
Pulmonary hypertension and follow-up
In general, only few reports investigate natural course of
persistent pulmonary hypertension of the newborn. In
infants with pulmonary hypertension in the neonatal period
due to chronic neonatal lung disease, echocardiographic
evidence of pulmonary hypertension was found in almost
25% of these patients after 2–5 years, while none of them
had clinical symptoms [86].
Most of the long-term consequences of pulmonary
vascular abnormalities in CDH patients are unknown [62].
As stated before, vascular abnormalities might contribute
to the development of pulmonary hypertension in CDH
patients in the neonatal period. In the first 3 weeks of life,
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pulmonary hypertension resolves spontaneously in almost
half of the CDH patients without the need for ECMO [87].
There are few studies describing pulmonary hyperten-
sion in CDH survivors beyond the neonatal period, in most
of these, patients were treated with ECMO [33, 88, 89].
Iocono et al. [89] identified seven patients with pulmonary
hypertension out of 40 CDH survivors at time of discharge,
by echocardiographic measurements. One of them died,
while the remaining six survived with normalization of
pulmonary vascular pressure at an average age of around
400 days. Schwartz et al. [88] documented that 8 of 21
CDH patients (age 3.2 ± 1.4 years) in their study group
met the criteria of pulmonary hypertension, such as right
axis deviation or right ventricular hypertrophy. Only two of
these seven patients desaturated mildly during the maximal
exercise test (one patient was too young to perform
the test). One of their patients, diagnosed with severe
pulmonary hypertension, eventually needed lung trans-
plantation [88].
Van Meurs et al. [33, 88] performed a complete car-
diological evaluation in 14 CDH survivors. All children
had normal auscultation and oxygen saturation. The
electrocardiogram showed evidence for right ventricular
hypertrophy in six of the 14 children; however, this
could also be related to cardiac malposition due to the
underlying pulmonary hypoplasia. In a group of 24 sur-
vivors of mild to moderate CDH, studied by Stefanutti
et al. [63], no echocardiographic signs of pulmonary
hypertension were found. Recently a nearly normal
resting and exercise cardiorespiratory function has been
reported in CDH survivors aged 10–16 years without
evidence for exercise-induced pulmonary hypertension
measured by echocardiography and maximal exercise
testing [72]. So far there is only one study describing
potential consequences in adulthood. Exercise capacity
and gas exchange parameters were normal in all 12 adult
CDH survivors, indicating these patients have a normal
pulmonary vascular bed [90].
Lung perfusion
There are several studies investigating long-term lung
perfusion of CDH survivors by performing pulmonary
perfusion scintigraphy. It has been demonstrated that in
survivors of left side hernia repair, mean perfusion of the
ipsilateral lung was lower than that in healthy children [48,
62–65] and in the contralateral lung [48, 62, 71]. Patients
who were ventilated for 4 days or more had poorer per-
fusion than patients who had required shorter ventilatory
support [48]. Secondary lung injury may play an important
role because ventilatory support and supplemental oxygen
were required for a long period of time [71].
Presence of persistent pulmonary hypoperfusion on the
side of the diaphragmatic defect suggests that an anatomic
impairment of variable degree is still present several years
after surgical repair in CDH patients and might reflect a
limited ability of the ipsilateral lung to develop additional
arterial branches [63, 71]. It has been speculated that,
because of persistence of poorly perfused ventilated areas
representing dead space, these patients have increased
intrapulmonary shunting and hypoxemia possibly leading
to pulmonary hypertension [62].
In summary, CDH has been associated with pulmonary
vascular abnormalities which may result in pulmonary
hypertension. Scintigraphic studies have shown that there
is persistent hypoperfusion on the affected side. The long-
term consequences are not clear.
Notably, all studies described above include a relatively
small number of patients and most studies contain a het-
erogeneous group of patients.
It is still complex to diagnose pulmonary hypertension
in an early stage because pulmonary hypertension may not
become evident until complaints resulting from a signifi-
cant degree of right heart failure become apparent. While
there are techniques enabling detection of pulmonary
hypertension in an early stage [91, 92], it is still unclear
whether routine assessment of these techniques is justified
as part of the long-term follow-up of CDH.
Gastro-intestinal morbidity
Gastro-esophageal reflux disease
Pathophysiology
Gastro-esophageal reflux disease (GERD) is a well-recog-
nized consequence of CDH. The mechanisms responsible
for GERD in CDH survivors have not been clarified and
several theories have been proposed.
Firstly, it has been suggested that elevated intra-
abdominal pressure, resulting from positioning the hernial
contents into the abdominal cavity, in combination with
reduced intra-thoracic pressure, increases the abdominal-
thoracic pressure gradient, which could predispose to
GERD [93, 94].
Secondly, abnormal anatomy of the gastro-esophageal
junction caused by the rudimentary or absent left dia-
phragmatic crus, might contribute to occurrence of
postoperative reflux [33, 95]. Especially when the stomach
initially was positioned in the chest, the lack of an intra-
abdominal esophageal segment following repair would
adversely affect the angle of His [71, 96]. The combination
of increased abdominal-intrathoracal pressure gradient and
underdevelopment of the diaphragmatic crus may increase
6 Pediatr Surg Int (2009) 25:1–17
123
the strain on the crus and result in an insufficient anti-reflux
barrier [97] and favorable conditions for hiatus hernia and
GERD [96, 97].
Thirdly, abnormality of the esophageal dimensions
might also contribute to development of GERD. The lesion
might be congenital and may result (in part) from extrinsic
pressure on the mediastinum and developing esophagus
caused by the herniated viscera very early in gestation.
Stolar et al. noted a mediastinal mass on plain chest
radiographs obtained after repair of CDH in 20 of 21
patients. Subsequent upper gastro-intestinal (UGI) series
showed it to be a dilated ectatic esophagus. After 5 years,
esophageal contour was still abnormal, while in 9 of 13
patients pathologic reflux was diagnosed by pH studies.
This phenomenon was also described by van Meurs et al.
[33]. In retrospective analysis of chest radiographs, they
identified a mega-esophagus in 40% of CDH survivors.
Incidence of GERD in the short term
According to most studies, the incidence of GERD in the
first years after repair ranges between 20 and 72% [33, 93,
96, 98–100]. Even higher incidences have been reported
[32]. The clinical presentation may vary, including recur-
rent vomiting or regurgitation, recurrent episodes of
bradycardia and respiratory arrest, failure to thrive and
recurrent pneumonia [96].
In the study by van Meurs et al. [33], symptoms con-
sistent with GERD were present in 16 of 18 children (CDH
patients treated with ECMO) during the initial hospital-
ization. At the time of discharge, 8 patients were receiving
nasogastric or gastrostomy tube feedings. One child
required a gastrostomy tube for severe failure to thrive.
None required surgical anti-reflux procedure. Koot et al.
[98] performed a prospective evaluation of GERD in
patients treated for CDH. Six months after closure of the
defect, 17 of the 31 patients had pathologic reflux on UGI
series. Nine patients were treated conservatively by main-
taining supine position and by frequent administration of
small amounts of oral nutrition. Seventeen patients (with
and without symptoms) received medical treatment. In
three patients, who did not respond sufficiently to this
treatment, Nissen fundoplication was performed. After
surgery, clinical parameters improved and investigations
confirmed disappearance of GERD [98]. In a study by
Fasching et al. [93], although 20 of 25 children had no
major clinical symptoms suggesting GERD in a follow-up
period of 1–17 years, GERD was demonstrated with UGI
series or 24-h pH studies in 8 of them. In contrast, of the 5
symptomatic children, only 2 actually had GERD, the other
3 having normal test results. Seven patients (28%) under-
went a surgical anti-reflux-procedure [93]. In the
retrospective study of Muratore et al. [99], 27 of the 45
CDH survivors appeared to have significant GERD con-
firmed by UGI series, 25 of them needing fundoplication.
Again it is difficult to accurately compare results of those
studies because each study varies regarding CDH severity,
postoperative CDH management (ECMO or not) and fol-
low-up period. Furthermore, different definitions for
GERD have been used, ranging from symptoms suggestive
for GERD to the need for antireflux surgery. Finally most
studies contain only a small group of patients, which
hampers the generalizability of the results.
Incidence of GERD in the long term
Reports concerning long-term gastro-intestinal morbidity
in adults with repaired CDH are scarce. Vanamo et al.
examined 60 of 107 CDH survivors aged 14–49 years. At
time of follow-up, 38 of them reported symptoms sugges-
tive of GERD, mainly heartburn and regurgitation.
Endoscopy showed macroscopic esophageal pathology in
12 of the 41 recruited patients, an alarming finding being
that Barrett’s esophagus was found in four patients.
Recently the first CDH survivor with esophageal adeno-
carcinoma has been described, 22 years after CDH repair
[101]. Vanamo et al. found that hiatus hernia was present in
30 patients, although as such this is not an uncommon
finding in the adult population in the western world [102].
The overall prevalence of esophagitis was 54%, which is
significantly higher than the expected 2% of endoscopi-
cally assessed esophagitis in the general adult population
[103, 104]. Predictive value of symptoms for detection of
esophagitis is poor: 6 of the 22 patients with esophagitis
were completely asymptomatic and only 14 of the 26
patients with heartburn or regurgitation had esophagitis.
Esophageal stricture was found in 2 of 11 patients with
early postoperative GERD [105].
Prediction of GERD in CDH survivors
Several authors have attempted to define clinical variables
that may predict GERD, with controversial outcomes. Koot
et al. [98] could not identify a specific predictive variable,
although they suggested a relation between duration of
artificial ventilation and development of GERD [98, 106].
Vanamo et al. [105] also reported a significant relation
between duration of ventilatory support and GERD. In
addition, they found that early postoperative GERD was
more common in patients with respiratory distress who had
been symptomatic within 6 h after birth. Furthermore,
postoperative intolerance of enteral feedings and prolonged
hospitalization were found predominantly in patients with
symptomatic GERD [105]. There might [79] or might not
[87] be an association between GERD and preoperative
thoracic position of the stomach.
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Fasching et al. [93] found no significant relation between
the size of the defect and occurrence of GERD, but they
found severe GERD in all three examined patients with a
patch. Yet, GERD appears to some extent to be related to
size of the diaphragmatic defect, because it was more fre-
quent and more severe in children requiring a prosthetic
patch [100, 107] or ECMO [28, 32, 33]. On the other hand,
use of a prosthetic patch could possibly diminish morbidity
related to GERD by lowering the strain on the left crus [96,
106]. Furthermore, the diaphragmatic patch may reduce
abdominal pressure and facilitate postoperative ventilation
[96]. This contrasts with results of other studies reporting
that requirement of a patch is an independent determinant
that predicts occurrence of GERD [99, 107, 108].
While the mechanism responsible for GERD in CDH is
still unclear, GERD as such is an important attribute of
overall short term and long term morbidity of CDH [105].
Other gastro-intestinal problems
Intestinal malrotation is obligatory in babies born with
CDH. It is assumed that this is related to abnormal posi-
tioning and fixation of the bowel in an abdomen that,
although reduced in size, has a wide communication with
the thorax. [109]. As a result, intestinal obstruction due to
midgut volvulus or adhesions occurs in approximately 10–
20% of CDH patients [32, 105, 110]. The most commonly
performed second surgical intervention in CDH is re-
exploration for small bowel obstruction [32, 110]. This
percentage is considerably higher than those of postoper-
ative intestinal obstruction in other patients who had
laparotomy in the neonatal period, infancy and childhood
(2.2–6%) and in patients who had Ladd’s procedure for
malrotation (8.3%) [111–113], but comparable to patients
operated for gastroschisis or omphalocele [114]. Several
mechanisms may contribute to the increased susceptibility
to intestinal obstruction among patients with diaphragmatic
defects. The malrotation predisposes to volvulus of the
intestine. The prolonged intestinal paralysis caused by
critical illness in the neonatal period and its treatment may
enhance adhesion formation. Increased intra-abdominal
pressure may further interfere with peristalsis [105].
Finally, non-specific abdominal problems such as hic-
cups, vomiting, meteorism, and abdominal pain occurred in
13.3% of the children during follow-up [59].
Failure to thrive
Pathophysiology
Failure to thrive has been noted in many CDH survivors
[32, 33, 60]. Pathophysiology of growth retardation in
CDH is complex and includes catabolic stress in the neo-
natal period, oral aversion, GERD and an increased caloric
requirement due to persistent pulmonary morbidity [108,
110].
Some authors reported that 20–30% of their patients
remain at or below the 5th percentile for weight, despite
optimization of caloric intake [108, 110]. Other studies
show that nutritional and growth problems are affecting
nearly half of the patients [32]. Several contributing factors
have been suggested, such as increased work of breathing,
prolonged ([4 months) oxygen dependency [33], poor
sucking ability, and GERD [32]. It has been demonstrated
that infants with broncho-pulmonary dysplasia also con-
tinue to have growth failure after hospital discharge, which
might be due to increased energy utilization and decreased
energy intake [115]. Inadequate tissue oxygenation may
also play a role, since it has been demonstrated that infants
with BPD and discharged with oxygen had less growth
failure than infants who were discharged without oxygen
[116], although this could not be confirmed for CDH
patients [33, 99]. The role of GERD is debatable, because
even after the reflux symptoms resolve, significant growth
failure remains. Another predictor of growth failure is the
need for ECMO [99, 110], CDH patients treated with
ECMO were found to have significantly lower weight,
length and weight/length percentiles when compared to
other ECMO patients [33] suggesting that CDH plays a
major role in growth failure.
Follow-up
Muratore et al. [99] reported that 56% of their population
was below 25th percentile for height and weight during the
first year of life, despite the fact that they were all born at
full term. Contributing to the observed growth failure were
feeding difficulties. Nearly one-quarter of their patients
displayed behavior consistent with oral aversion. Duration
of ventilation was the only independent determinant that
predicted development of oral aversion. They speculated
that prolonged endotracheal intubation might contribute to
a delay in development of the swallowing reflex or the
suckling mechanism. One-third of the patients in this study
required gastrostomy tube placement for adequate caloric
intake. Despite this, several patients still showed evidence
of growth failure that appeared to be due to GERD [99]. On
the other hand, according to Kamiyama et al. [106] early
GERD does not seem to have a significant influence on
physical development of these patients. They found no
significant difference with respect to body weight between
CDH patients with and without pathologic GERD in the
early postoperative period [106]. Fluid restrictions as well
as diuretics are required to prevent pulmonary vascular
overload. In order to meet caloric needs in this situation,
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high energy density formulas are required, so the majority
of these children have enriched feedings.
In the study by van Meurs et al. [33], 15 children with
CDH treated with ECMO were compared with 15 ECMO-
treated children with other diagnoses (controls). All were
within normal (5–95) percentiles for weight, length and
head circumference at birth, although 4 of the 15 CDH
infants (27%) were less than the 5th percentile for weight-
length ratio as compared to 2 of the control subjects. In the
first 2 years of life, weight gain was significantly lower in
the CDH group as compared to the ECMO treated, weight-
matched control subjects without CDH. In the report by
Davenport et al. [117], of 23 children born with CDH, only
1 was below the 10th centile for height while 6 were below
the 10th centile for weight. They found a significant
inverse correlation between attained weight centile and
duration of ventilation as well as of hospital stay.
In summary, it appears that many CDH survivors
experience growth failure. There are several attributes to
growth failure, including persistent pulmonary morbidity
resulting in increased caloric requirements, feeding prob-
lems due to a postoperative ileus, need for ECMO, GERD
and oral aversion, especially when endotracheal intubation
and prolonged ventilation are needed.
We conclude that all CDH patients should therefore
undergo routine nutritional assessments with emphasis on
weight, height, weight-for-height ratio, growth velocity and
measurements of head circumference. Early intervention
by nutritional specialists may avoid prolonged oral aver-
sion, improve weight and length accretion and foster
normal developmental milestones.
Neurodevelopmental outcomes
Neurocognitive defects
Although approximately half of the CDH cases occur as
isolated malformations with normal brain development,
neurodevelopmental outcome of these infants may be
affected by acquired (e.g., hypoxia) neurologic insults
secondary to CDH. For the 50% of infants with a co-
existing anomaly, about 7% has anomalies of the central
nervous system [8]. When these associated anomalies can
be assigned to a syndromal diagnosis, neurodevelopmental
outcome is generally poor.
Children born with CDH have high risk of hypoxemia at
varying stages of their postnatal management due to the
combination of pulmonary hypoplasia and persistent pul-
monary hypertension. Persistent hypoxemia has a
significant correlation with developmental delays [32, 118]
possibly due to ischemia/reperfusion injury to the brain and
loss of autoregulation of cerebral blood flow [119].
Neurological abnormalities in the neonatal period
Several neurological abnormalities in CDH survivors have
been documented in the literature. Hunt et al. performed
MR imaging at a median postnatal age of 25 days in 8
infants treated for CDH (non-ECMO). Abnormalities
were detected in all 8 infants, in only 1 of these infants
the abnormality had already been identified on cranial
ultrasound. There were abnormalities of varying severity
found in every infant who was already weaned from
mechanical ventilation, including ventricular dilatation,
abnormal signal in the white matter and basal ganglia,
and abnormal myelination of posterior limb of the intern
capsule. Van Meurs et al. [33] described that CT scans in
4 out of 17 CDH survivors treated with ECMO were
normal. Ten children had minor abnormalities such as
petechial hemorrhages, mild ventricular enlargement or
widening of the interspheric fissure and three children had
major abnormalities including cerebellar hemorrhages and
hemorrhages in the basal ganglia. The ventricular dilation
might reflect loss of white matter as a consequence of
ischemia in the vulnerable immature periventricular white
matter. It is hypothesized that inflammation might also
play a role. Clearly surgery presents a significant
inflammatory response [120], which may contribute to
cerebral white matter injury [121]. The long-term impli-
cations of the abnormalities detected on MRI are
unknown.
Long-term follow-up
Lund et al. [32] performed CT studies of the brain in all 33
CDH-survivors, showing marked bifrontal atrophy or
ventricular dilation or a combination of both in 10 patients.
All but one patient was treated with ECMO. During follow-
up, head CT findings improved with growth. None of the
children described in the study above had a syndromal
diagnosis.
In patients treated with ECMO, including CDH-survi-
vors, neurological deficits have been reported in 10–30% of
patients [122–127]. Stolar et al. [128] investigated the role
of CDH in ECMO-treated infants with CDH by comparing
ECMO survivors with CDH to other ECMO survivors.
They concluded that, diagnosis of CDH (among ECMO
survivors) did not contribute independently to neurological
risk. In contrast, a significant correlation has been found
between CDH and a poorer cognitive outcome especially in
boys. CDH infants appeared to be more unstable while on
ECMO, have more complications, and they are the only
infants treated with ECMO that require surgery [128],
which contributes to an inflammatory response [120].
According to McGahren et al. [129] ECMO-treated
newborns with CDH had a higher incidence of adverse
Pediatr Surg Int (2009) 25:1–17 9
123
neurological sequelae than non-ECMO treated neonates
with CDH.
There is only one study concerning neurodevelopmental
outcome of patients treated with fetal TO. Cortes et al. [44]
studied 16 CDH survivors, 7 of them were treated with
fetal TO. They found no differences between groups in
neuromotor, cognitive or composite neurodevelopmental
outcomes at 1 year or 2 years adjusted age.
Few studies report on cognitive development of CDH
children not treated with ECMO. Bouman et al. studied 11
CDH-survivors (age 8–12 years) and found a mean IQ of
85, while almost half of the children obtained IQ scores
around or more than 1 standard deviation below normal.
They did not find differences in intelligence, school level,
or adaptive functioning between high-risk (hospitalized
within 1 day after birth because of progressive respiratory
insufficiency and ventilated for more than 10 days) and
low-risk (other) children. The children showed signifi-
cantly more emotional and behaviorial problems than
expected and more children than expected had depressive
problems [130]. It has to be noted, however, that the
number of participants (n = 11) in this study was rather
small.
Davenport et al. [117] reported that neurological
examinations (including hearing and vision) showed no
abnormalities in 19 of 23 patients treated for CDH (non-
ECMO) at a median age of 56 months. Of the remaining
four infants, two had a major disability and two a minor
disability. None of them had developmental delays
according to the Griffith’s mental developmental scales,
suggesting that potential improvement in survival with
delayed surgery does not occur at the expense of poor
neurological outcome or developmental delay in survivors.
Using the Bayley Scales or the Stanford-Binet intelli-
gence scale, Van Meurs et al. [33] tested 7 of the 15 CDH
survivors (age 8 months-5 years) treated with ECMO
normal, three were suspected to be delayed (score\90) and
two were definitively delayed (score \70). Three children
were unavailable for testing without reason. Similar results
were reported by Chen et al. [131].
Predictive factors of neurological outcome
Not only use of ECMO can affect neurological outcome in
CDH patients [129], but also the ECMO modality that has
been chosen can affect neurological outcome. Standard
ECMO modality for rescue of CDH patients has been
venoarterial (VA) ECMO because circulatory support can
be continued during ECMO [132]. Recent studies however
have shown that venovenous (VV) ECMO is as efficient
in supporting CDH patients as VA ECMO, while the
rate of adverse neurologic sequela is lower [133, 134].
A decreased right internal carotid artery blood flow in
patients treated with VA ECMO [135] might explain the
fact that these patients have more neurological complica-
tions such as seizures and cerebral infarction, when
compared to VV ECMO treated patients [134].
Several characteristics of CDH, the presentation of CDH
and the clinical course, such as the need for a patch closure
or gastrostomy tube are also significantly associated with
neurological outcome [129]. These factors may reflect the
severity of the presentation of CDH [129]. This was con-
firmed by D’Agostino et al. [136], they found a difference
between children (tested at the age of 1 year) who had a
primary diaphragmatic repair and those who needed patch
closure. Children with primary repairs had mean mental
and motor skills in the average range, whereas mean scores
for those required patch closure were in the abnormal
range. They also showed that 7 of the 13 infants with CDH,
treated with ECMO had normal mental and motor skills, 3
had normal mental functioning but delayed acquisition of
motor milestones, and 3 had mental and motor delay at the
age of 12 months [136]. Eleven children had muscle tone
abnormalities [136]. This study also contained a small-
sample size and it remains unclear whether these findings
are related to CDH, ECMO or to general management.
In summary, evidence indicates that not only children
with CDH requiring ECMO are at risk for cognitive
problems. As children with CDH not treated with ECMO
appear to have a reduced level of intellectual and school
functioning, all children with CDH may be at risk for
cognitive delay. This could be due to several factors, which
can interfere with central nervous system development,
such as perinatal and postnatal hypoxia, hypercapnia, and
acidosis. These are the most frequent problems in children
born with CDH either in the immediate postnatal period or
during the course of stay in the intensive care unit. Most
studies focus only on the first 5 years after CDH repair. In
addition the small sample size and the disparate results
indicate that there is a need for further follow-up studies of
children with CDH, because serious problems in long-term
psychosocial functioning may be expected.
Hearing loss
Hearing loss has been a troubling and frequent finding and
may be due, at least in part, to side effects of treatment.
Treatment of newborns with persistent pulmonary hyper-
tension used to consist of hyperventilatory induced
alkalosis. These infants were exposed to significantly
higher pH values for longer periods and needed longer
durations of mechanical ventilation resulting in approxi-
mately 35% of children requiring hearing aids [110, 137,
138]. Hypoxemia, induction of alkalosis and use of oto-
toxic medication are believed to be important causal
factors, but the specific insult that leads to progressive
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hearing loss remains unclear [139]. In addition to ototoxic
medication and ventilatory treatment, ECMO therapy is an
additional risk factor for hearing loss in CDH survivors
[110, 122]. Lund et al. [32] found that hearing aids were
required in 21% of CDH survivors treated with ECMO.
Another 21% had abnormal brain auditory evoked response
(BAER) or latency intensity studies (LIS) results, but
hearing loss could not be confirmed by audiometry. Six of
the seven children that required hearing aids had been
treated with ECMO. D’Agostino et al. [136] described that
1 of the 16 studied children with CDH suffered hearing loss
that was detected by brainstem auditory evoked response
testing at 11 months of age.
In the report from Rasheed et al. [140], CDH patients
requiring ECMO before surgery had a higher incidence of
hearing loss when compared with those requiring ECMO
after CDH repair, which might be secondary to the pro-
longed period of hyperventilation or general intensive care.
Morini et al. [141] reported that 40 of the 82 CDH
survivors (non-ECMO) had sensineural hearing loss
(SHNL) at audiologic follow-up at a median age of
3.0 years. Patient’s age at follow-up was the only inde-
pendent predictor for SNHL.
It is recommended for CDH patients, especially when
treated with ECMO, to undergo regular hearing tests in
their preschool years, particularly if there is any delay in
speech or language skill development [110].
Musculoskeletal abnormalities
Chest wall deformities
Chest wall deformities are present in approximately 16–
48% of the CDH survivors. The majority of patients have a
pectus excavatum [32, 59, 64, 68, 142]. The close rela-
tionship between development of the lung, diaphragm, and
thoracic cage is the reason that deformities of the chest
wall are more common in patients with CDH [32]. Several
factors contribute to thoracic deformities. First of all the
thoracic cavity on the affected side may be reduced in size
due to the smaller lung volume. Secondly, the increased
work of breathing in these children may contribute to the
development of a pectus abnormality [32, 110] because
more negative intrapleural pressure is required to inflate the
lungs [142]. Thirdly more negative intrathoracic pressure
promotes retraction of the chest wall in its most compliant
section, the cartilaginous anterior wall [142]. Postoperative
empyema has been shown to increase the likelihood of
postoperative thoracic deformity [143, 144]. Since chest
wall deformities are more common among patients with
anatomically large diaphragmatic defects, it is suggested
that repair of a large defect causes tension, interfering with
normal development of the thoracic cage and promoting
asymmetry and/or flat chest [142].
It has been suggested that CDH patients with a clinically
asymmetric chest and scoliosis are prone for pulmonary
function impairment [65, 68]. In other CDH patients with
pectus excavatum, a reduced lung function compared to
normal CDH patients has been demonstrated [70, 145]. It
is, however, controversial whether a Nuss procedure results
in an improvement in pulmonary function [145–147].
Scoliosis
Mild to moderate thoracic scoliosis has been reported in
5–10% of CDH-survivors [59, 63, 110]. In most of the
studies, only small numbers of patients are included [59,
63, 110]. Lund et al. [32] described that 4 of 33 patients
had thoracic scoliosis concave towards the hernia side, only
one of them required bracing. The only study focusing
primarily on chest wall deformities and scoliosis in CDH
patients came from Vanamo et al. [142] describing sixteen
(27%) patients with significant radiological scoliosis
(Cobb’s angle C10). The mean curve was significantly
greater in patients with a large defect. There was no sig-
nificant difference in the incidence of scoliosis between
patients with a diaphragmatic hernia and those with
eventration.
It can be concluded that chest wall deformity and spinal
deformities are common among patients with repaired
diaphragmatic defects [142]. Scoliosis should particularly
be kept in mind when determining how much tension to use
when closing a hernia defect [32]. In the majority, defor-
mities are mild and rarely have therapeutic consequences
or impact on daily life. However, as more children with
severe diaphragmatic defects are expected to survive with
use of new treatment modalities, number of patients with
severe thoraco-spinal deformities may increase in the
future [142].
Overall health-related quality of life
Although the prevalence of co-morbidity is high among
CDH survivors, little is known about the impact of long-
term health problems on overall well being of these
patients. There are only two studies describing health-
related quality of life (HR-QoL) of CDH patients. Poley
et al assessed HR-QoL in 111 CDH patients (4 treated with
ECMO), 286 patients with anorectal malformations (ARM)
and a healthy control group (age 1–52 years). In children
aged 1–4 years, influence of symptoms on HR-QoL,
assessed with the TAIQOL (quality of life questionnaire
developed for children between ages of 1 and 4 years
[148]), seemed less profound in CDH patients when
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compared to ARM patients in most domains. Statistically
significant differences between the CDH group and the
control group were found in five domains of the TAIQOL.
CDH patients aged 5–15 years scored relatively low in
the domains ‘‘basic motor functioning’’ and ‘‘cognitive
functioning’’ in the TACQOL (quality of life questionnaire
developed for children between the ages of 5 and 15) [149].
Neither the 8 domains of the widely used Short Form 36
(SF-36) domains, used for patients aged 16 years and
above, nor the physical summary measure discriminated
between CDH patients and the general population [150].
Koivusalo et al. [73] studied 69 adult survivors of
congenital diaphragmatic defects (CDD) consisting of
survivors of CDH and diaphragmatic eventration (DE) in
comparison with a healthy control group. None of the
patients with DE underwent preoperative stabilization with
medication or mechanical ventilation, and only 15%
required mechanical ventilation for more than 1 week
postoperatively. The frequency of high educational level
was significantly lower in patients with CDD than in
control subjects, but whether this difference was related to
long-term sequelae of CDD remained unclear. A total of 17
of the 69 patients (25%) with CDD had low HR-QoL
assessed in one or both of the summary measures Physical
Health and Mental Health in SF-36 questionnaires. No
statistical difference in quality of life was found between
patients with CDH and DE. Incidence of GERD and
recurrent intestinal obstruction was most often associated
with low HR-QoL and Gastro-Intestinal Quality of Life
(GIQLI) scores in patients with CDD. This study indicates
that 75% of adult patients born with CDD have good HR-
QoL similar to healthy subjects. Practically no or insig-
nificant late sequelae associated with CDD were found.
Low HR-QoL was found in 25% of the patients, exceeding
the expected figure of 16% [73].
It is likely that, in the past, major selection took place in
the first week of life due to high mortality in patients with
severe pulmonary hypoplasia and therapy resistant pul-
monary hypertension. ECMO nowadays might enable
survival of patients with a relatively poor prognosis leading
to iatrogenic morbidity [150]. While CDH is associated
with considerable symptoms, so far available research in
adults suggests a favorable long-term outlook for the vast
majority of patients [73, 150], however, there are no studies
describing HR-QoL in CDH survivors treated with ECMO.
Conclusion
Despite new therapeutic strategies including ECMO,
inhalation of nitric oxide, high frequency oscillation and
fetal TO, mortality rate of CDH remains high. Several
studies have documented significant long-term morbidity.
Infants born with CDH have pulmonary vascular
abnormalities, presumably causing pulmonary hyperten-
sion. There is a higher incidence of obstructive airway
disease and restrictive lung function pattern among CDH
survivors. Gastro-esophageal reflux disease sometimes in
combination with failure to thrive is a well recognized
complication and several patients require anti-reflux sur-
gery. It is unknown whether GERD has an effect on the
pulmonary function.
Pulmonary hypoplasia and persistent pulmonary hyper-
tension predispose children born with CDH to a high risk
of hypoxemia, which may result in neurodevelopmental
delay.
Chest wall deformities and scoliosis are more common
among CDH patients. Deformities are mild and surgery is
rarely required.
Despite the significant morbidity due to CDH, limited
numbers of quality of life studies in older patients suggest
that the majority of patients apparently enjoy quite healthy
lives.
It should be realized that, with the introduction of
potential mortality reducing new therapies in the acute
(neonatal) phase, the balance between decreasing early
mortality and potential long-term outcome should be
assessed.
It is therefore be, highly recommended that children
born with CDH are evaluated periodically in a protocolized
multidisciplinary setting to minimize short-term morbidity
and to assess long-term morbidity. Particularly the study of
long-term sequelae will enable to establish an adequate and
focused program for routine follow-up of survivors of a
severe congenital anomaly.
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